Loading company…
Sirna Therapeutics develops RNA interference-based treatments for human diseases.
Founded in 1992, Sirna Therapeutics develops therapeutics based on RNA interference technology for human diseases, including dermatological, respiratory, metabolic, neurological, ocular, oncological, and antiviral conditions. The company is based in Boulder, US, and is listed as Public.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in